Home » Topics » Regulatory » Patents

Patents
RSS

Chinese researchers disclose BCL2 mutant inhibitors

May 23, 2022

Sichuan Kelun-Biotech Biopharmaceutical patents Raf/Ras kinase inhibitors

May 23, 2022

Chulalongkorn University presents compounds for treating hepatitis B virus infections

May 20, 2022

Spectrum Pharmaceuticals divulges G12C mutant GTPase KRAS inhibitors

May 20, 2022

Mount Sinai School of Medicine patents ATP6V1A gene expression enhancers

May 20, 2022

New CTP synthase 1 inhibitors discovered at Nimbus Clotho

May 20, 2022

Auransa identifies new agents for bacterial and fungal infections

May 20, 2022

New YAP1-TEAD interaction inhibitors identified at Vivace Therapeutics

May 19, 2022

TME Therapeutics discovers PIKfyve inhibitors

May 19, 2022

CXCR4-targeting compounds patented by the University of British Columbia, PHSA

May 19, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...